Duke University oncologist Amy Abernathy says the policy shift towards more comparative effectiveness research presents some problems for researchers doing work in cancer, reports Scientific American's Katherine Harmon. The first problem, Harmon writes in the Observations blog, is that comparative effectiveness research focuses on broad populations of patients, but that oncology is about individual treatment.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.